Ionis Pharmaceuticals
Ionis Pharmaceuticals is a biopharmaceutical company known for its pioneering work in RNA-targeted drug discovery and development. The company specializes in designing and developing therapies for a variety of diseases, including genetic disorders, cancers, and cardiovascular diseases. In recent news, Ionis Pharmaceuticals was mentioned in the context of Novartis' recent setbacks in drug development, particularly regarding a collaboration on a cardiovascular drug that did not meet its efficacy targets in clinical trials.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 5.00 | 0.19% | +0% | 8,654,622 | 16,422 | $700,000 | 1,328$ |
| Totals | 1 | 8,654,622 | 16,422 | $700,000 | 1,328$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Ionis Pharmaceuticals is mentioned as a partner company that would share the revenues from a potential blockbuster drug.
5